Because informed decisions lead to better outcomes As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 …

Sectors: Publishing

Head and Neck Expertise. Created in 1905 in the 19th district of Paris, the Adolphe de Rothschild Foundation Hospital is a private health institution of collective interest (ESPIC) specialized in all pathologies of the head and neck for adults and children. This university hospital offers excellent care at a conventional rate (non-profit) and treats nearly 300,000 patients every year. Providing the continuum of care, research and training, the Rothschild Foundation Hospital pilots 125 clinical research studies each year, publishes nearly 300 scientific articles and trains nearly 700 students. The services of the Rothschild Foundation Hospital regularly appear at the top …

Sectors: NGO, Think Tank

Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. …

Sectors: Biotechnology

[Automatic translation follows] First mutual insurance company for public service employees. #mutually Cyril, Diane, Farah, Amir, Béa... Since 1946, MGEN has been committed to all those who are committed to the interests of others. With 4.2 million people protected, 10,000 employees and 3,500 activists, MGEN is the first mutual insurance company for public service employees. Its unique model in France allows it to manage health insurance, supplementary health insurance and life insurance, whether individual or group contracts. It provides everyone with 1,700 mutual care and support structures that it co-manages and co-finances throughout France, 62 of which belong to MGEN. …

Sectors: Insurance

[Automatic translation follows] International Center for Biomedical and Translational Research INEM is a research center under the supervision of Inserm, Université Paris Cité and CNRS. INEM brings together nearly 300 professionals spread across 21 research teams and research support services. Research at INEM focuses on diseases caused by the interaction between heredity and environmental factors. These diseases mainly affect children and young people, and include (auto)immune disorders, hematological diseases, infectious diseases, kidney diseases, cystic fibrosis, endocrinological disorders and metabolic diseases. INEM teams apply knowledge from basic and clinical research to develop innovative diagnostic and therapeutic strategies. The close interaction between …

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Karista is a VC firm investing in game changers from scratch to success. Karista is an early-stage venture capital firm investing in ambitious entrepreneurs. For the past 20 years, we have been backing and guiding more than 100 companies from inception to success in Health, Digital, and Technology. Because we believe that investment is not only about money but mainly about people, we provide support to our founders and entrepreneurs very early-on. We come from different backgrounds and bring various skills to help nurturing our portfolio companies on many levels. We are currently deploying three European early stage funds: our …

Sectors: Startup accelerator & VC

[Automatic translation follows] Inspire and equip citizens, entrepreneurs and organizations to build an inclusive and sustainable society. Time is running out, the challenges we face are immense. Companies will be part of the solution and we support them in doing so, collectively. At makesense, we support companies, institutions and associations to become ever more sustainable, committed and resilient. How? We give back the power to act to all those who make up the company, every day. - We support organizations in defining their purpose, their values ​​and their impact strategy. - We engage employees around this vision, through training in …

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par …

Sectors: Health

The French national research institute for digital science and technology World-leading research and technological innovation are an integral part of its DNA. Inria's 3,500 researchers and engineers put their passion for digital technology to work in nearly 200 project teams, most of which are joint teams with our academic partners, including major research universities and the CNRS. They explore new fields, often in collaboration with different disciplines and industrial partners, with the aim of meeting ambitious challenges. As a technology institute, Inria supports the development of numerous software products, sometimes making a global impact via the opensource model. Because technology …

Sectors: Research

Together, beyond animal health Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our …

Sectors: Animal Health Pharmaceutical

[Automatic translation follows] Prevention / Care / Research / Education, at the service of patients with #cancer. Gustave Roussy, the leading cancer center in Europe, the 4th best cancer hospital in the world, is a global center of expertise against cancer, at the service of patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Greater Paris). A private institution of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and education

Sectors: Health

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical